1-(4-Chlorophenyl)-3-Methyl-2-Pyrazolin-5-One

We are 1-(4-Chlorophenyl)-3-Methyl-2-Pyrazolin-5-One CAS:13024-90-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 1-(4-Chlorophenyl)-3-Methyl-2-Pyrazolin-5-One
CAS.NO:13024-90-3
Synonyms:1-(4-Chlorophenyl)-3-methyl-2-pyrazolin-5-one;1-(4-Chlorophenyl)-3-Methyl-5-pyrazolone
Molecular Formula:C10H9ClN2O
Molecular Weight: 208.64400
 
Physical and Chemical Properties:
Density:1.306 g/cm3
Boiling point:325.9ºC at 760 mmHg
Melting point:167-171 °C(lit.)
Flash point:150.9ºC
Index of Refraction:1.625
 
Specification:
Appearance:Light yellow crystalline powder
Purity:≥98.0%
 
Packing: 25kg drum
Storage:This product should be sealed in a cool dry place.
Application:Mainly used for organic synthesis C.I. Acid orange 87; 88 and other varieties of coupling components.

1-(4-Chlorophenyl)-3-Methyl-2-Pyrazolin-5-One


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.2-(1,3,2-Dioxaborinan-2-yl)benzonitrile APIs are generally manufactured through a variety of processes that include.4-Isopropylaniline In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.(3,3,3-Trifluoropropyl)Methyldichlorosilane The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.

Related Products
Product Name
(3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid View Details
6-chloro-4-iodopyridin-3-ol View Details
5-bromo-2-chloro-4’-ethoxydiphenylmethane View Details
2-methyl-2-oxazoline manufacturer Chroman-4-one manufacturer 3-Bromo-2-fluorotoluene manufacturer Hexadecanethiol manufacturer rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid manufacturer